| scholarly article | Q13442814 |
| P50 | author | Frede Donskov | Q43282917 |
| Ziad Bakouny | Q52981871 | ||
| Ulka Vaishampayan | Q86981393 | ||
| Toni K Choueiri | Q88414622 | ||
| P2093 | author name string | Camillo Porta | |
| Georg A Bjarnason | |||
| Takeshi Yuasa | |||
| Daniel Y C Heng | |||
| Sumanta K Pal | |||
| Aaron Hansen | |||
| J Connor Wells | |||
| Lori A Wood | |||
| Benoit Beuselinck | |||
| Guillermo de Velasco | |||
| Nazli Dizman | |||
| Jeffrey Graham | |||
| Shaan Dudani | |||
| Flora Yan | |||
| Marco Iafolla | |||
| Elizabeth Liow | |||
| P433 | issue | 6 | |
| P921 | main subject | immuno-oncology | Q16979420 |
| P304 | page(s) | 861-867 | |
| P577 | publication date | 2019-08-22 | |
| P1433 | published in | European Urology | Q15763991 |
| P1476 | title | First-line Immuno-Oncology Combination Therapies in Metastatic Renal-cell Carcinoma: Results from the International Metastatic Renal-cell Carcinoma Database Consortium | |
| P478 | volume | 76 |
| Q92541901 | Biomarkers of Prognosis and Efficacy of Anti-angiogenic Therapy in Metastatic Clear Cell Renal Cancer |
| Q90116668 | Combining Immune Checkpoint and VEGFR Inhibition in Favorable Risk and Elderly Patients With Metastatic Renal Cell Carcinoma |
| Q96811984 | Cytoreductive Nephrectomy in the Era of Tyrosine Kinase and Immuno-Oncology Checkpoint Inhibitors |
| Q92920319 | MTDH promotes metastasis of clear cell renal cell carcinoma by activating SND1-mediated ERK signaling and epithelial-mesenchymal transition |
| Q98466875 | Retrospective comparison of the different immune combinations in metastatic renal cell carcinoma |
| Q96811967 | Sequencing Therapies for Metastatic Renal Cell Carcinoma |
| Q90671025 | Tyrosine kinase inhibitors and immunotherapy combinations in renal cell carcinoma |
| Q90160018 | Vascular endothelial growth factor and programmed death-1 pathway inhibitors in renal cell carcinoma |
Search more.